Artesunate rectal capsules
Therapeutic indication |
|
Dosing |
|
Efficacy |
|
Key features |
|
Challenges |
|
Status |
|
Next milestone | |
Previously |
|
Project Director |
|
Footnotes:
* Lower age limit specified as 2 months in WHO Public Assessment Report part 4 (November 2018)
** Combined data from Cipla and Strides up to and including 2021